Cencora(COR)
Search documents
Here's Why Cencora (COR) is a Strong Growth Stock
Zacks Investment Research· 2024-04-12 14:50
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium also includes the Zacks Style Scores.What are the Zacks Style Scores?The Zacks Style ...
Cencora, Inc. (COR) Soars to 52-Week High, Time to Cash Out?
Zacks Investment Research· 2024-04-04 14:16
Shares of Cencora (COR) have been strong performers lately, with the stock up 4.7% over the past month. The stock hit a new 52-week high of $246.75 in the previous session. Cencora has gained 19.7% since the start of the year compared to the 5.9% move for the Zacks Medical sector and the 5.6% return for the Zacks Medical Services industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the las ...
Here's Why Cencora (COR) is a Strong Value Stock
Zacks Investment Research· 2024-03-29 14:47
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores.What are the Zacks Style Scores?Developed a ...
3 Medical Services Stocks to Buy as Industry Trends Improve
Zacks Investment Research· 2024-03-13 16:51
The Medical Services sector is evolving at a rapid pace. The pandemic years reshaped the market dynamics within this sector in a profound way and on a permanent basis. The need for remote monitoring and distant treatment has paved the way for digital services. Even though the pandemic has ended, digital healthcare treatment continues to be indispensable, backed by the adoption of data and analytics. Telemedicine-focused online medical and AI-powered technology services, which flourished during the pandemic, ...
Why Cencora (COR) is a Top Value Stock for the Long-Term
Zacks Investment Research· 2024-03-13 14:46
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores.What are the Zacks Style Scores?Developed a ...
Cencora Announces Leadership Succession Plan
Businesswire· 2024-03-12 12:30
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that Steven H. Collis will retire as President and Chief Executive Officer of the Company and transition to the role of Executive Chair of the Cencora Board of Directors, effective October 1, 2024. Robert P. Mauch, PharmD, PhD, current Chief Operating Officer of Cencora, will succeed Collis as President and CEO, and will also be appointed as a member of the Company's Board, effective the same date. “Steve’s 30-year career at Ce ...
Cencora (COR) Is Up 2.40% in One Week: What You Should Know
Zacks Investment Research· 2024-02-28 18:01
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock char ...
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?
Zacks Investment Research· 2024-02-27 15:16
Have you been paying attention to shares of Cencora (COR) ? Shares have been on the move with the stock up 9.1% over the past month. The stock hit a new 52-week high of $239.86 in the previous session. Cencora has gained 16.1% since the start of the year compared to the 7.8% move for the Zacks Medical sector and the 5.7% return for the Zacks Medical Services industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensu ...
3 Medical Services Stocks to Buy Amid Industry Headwinds
Zacks Investment Research· 2024-02-09 16:36
The Medical Services sector is evolving at a rapid pace. The COVID-19 pandemic accelerated the transition to remote treatment options. Even though the pandemic has ended, digital healthcare treatment continues to be indispensable, backed by the adoption of data and analytics. Telemedicine-focused online medical and AI-powered technology services, which flourished during the pandemic, continue to witness significant demand.Going by a recent WNS report, the global healthcare analytics market is expected to su ...
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
Businesswire· 2024-02-07 23:26
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale of Cencora shares pursuant to Rule 144 under the Securities Act of 1933, as amended. Cencora intends to repurchase shares from Walgreens Boots Alliance at the price per share equal to the price in the Rule 144 sale. The concurrent shar ...